These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22713225)

  • 1. [Hyperprolactin as cause of hypoactive sexual desire in men].
    Baltzar MT; Anholm C; Petersen CD
    Ugeskr Laeger; 2012 Jun; 174(25):1745-6. PubMed ID: 22713225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia.
    Colao A; Di Sarno A; Cappabianca P; Di Somma C; Pivonello R; Lombardi G
    N Engl J Med; 2003 Nov; 349(21):2023-33. PubMed ID: 14627787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current diagnosis and treatment of hyperprolactinemia].
    Melgar V; Espinosa E; Sosa E; Rangel MJ; Cuenca D; Ramírez C; Mercado M
    Rev Med Inst Mex Seguro Soc; 2016; 54(1):111-21. PubMed ID: 26820213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia.
    Colao A; Sarno AD; Cappabianca P; Briganti F; Pivonello R; Somma CD; Faggiano A; Biondi B; Lombardi G
    Eur J Endocrinol; 2003 Mar; 148(3):325-31. PubMed ID: 12611613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma.
    Gillam MP; Middler S; Freed DJ; Molitch ME
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4447-51. PubMed ID: 12364416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anejaculation as the presenting feature of pituitary microadenoma.
    Nair S; Milsom S
    Fertil Steril; 2008 Nov; 90(5):2012.e21-3. PubMed ID: 18394608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Massive reduction of tumour load and normalisation of hyperprolactinaemia after high dose cabergoline in metastasised prolactinoma causing thoracic syringomyelia.
    van Uum SH; van Alfen N; Wesseling P; van Lindert E; Pieters GF; Nooijen P; Hermus AR
    J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1489-91. PubMed ID: 15377706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical practice. Prolactinoma.
    Schlechte JA
    N Engl J Med; 2003 Nov; 349(21):2035-41. PubMed ID: 14627789
    [No Abstract]   [Full Text] [Related]  

  • 9. Unusual late development of dopamine agonist resistance in two women with hyperprolactinaemia associated with transition from micro to macroadenoma.
    McCall D; Hunter SJ; Cooke RS; Herron B; Sheridan B; Atkinson AB
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):149-50. PubMed ID: 17201816
    [No Abstract]   [Full Text] [Related]  

  • 10. Osteopenia in children and adolescents with hyperprolactinemia.
    Galli-Tsinopoulou A; Nousia-Arvanitakis S; Mitsiakos G; Karamouzis M; Dimitriadis A
    J Pediatr Endocrinol Metab; 2000 Apr; 13(4):439-41. PubMed ID: 10777000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose cabergoline therapy for a resistant macroprolactinoma during pregnancy.
    Banerjee A; Wynne K; Tan T; Hatfield EC; Martin NM; Williamson C; Meeran K
    Clin Endocrinol (Oxf); 2009 May; 70(5):812-3. PubMed ID: 18803677
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacologic cure of a pituitary macroprolactinoma].
    Hurtado Amador R; Ayala AR
    Ginecol Obstet Mex; 2003 Oct; 71():522-6. PubMed ID: 15002692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperprolactinemia unrelated to prolactinoma].
    Krysiak R; Okopień B
    Wiad Lek; 2014; 67(2 Pt 1):101-11. PubMed ID: 25764785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactinoma presenting as painful postganglionic Horner syndrome.
    Talkad AV; Kattah JC; Xu MY; Orth EH; Chang JY
    Neurology; 2004 Apr; 62(8):1440-1. PubMed ID: 15111696
    [No Abstract]   [Full Text] [Related]  

  • 15. [Symptomatic episodic cluster headache as the first symptom of a prolactinoma].
    Soto-Cabrera E; Chávez-Valencia V; Zermeño-Pohls F; González-Aguilar A
    Rev Neurol; 2009 Aug 1-15; 49(3):165-6. PubMed ID: 19621313
    [No Abstract]   [Full Text] [Related]  

  • 16. [Simultaneous defect of visual fields and loss of libido--a coincidence?].
    Jenni S; Seiler R; Christ ER; Stettler C
    Praxis (Bern 1994); 2006 Dec; 95(49):1925-30. PubMed ID: 17212311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy.
    Kharlip J; Salvatori R; Yenokyan G; Wand GS
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2428-36. PubMed ID: 19336508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactinomas.
    Couldwell WT; Weiss MH; Laws ER
    N Engl J Med; 2004 Mar; 350(10):1054-7; author reply 1054-7. PubMed ID: 15002121
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical presentation of hyperprolactinemia.
    Luciano AA
    J Reprod Med; 1999 Dec; 44(12 Suppl):1085-90. PubMed ID: 10649815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactinomas and pregnancy.
    Molitch ME
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):147-8. PubMed ID: 20550542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.